Transferrin Immobilized Graphene Oxide Nanocomposite for Targeted Cancer Chemodynamic Therapy via Increasing Intracellular Labile Fe 2+ Concentration
ACS Applied Bio Materials · 2024
DOI: 10.1021/acsabm.3c01147 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Ashish K Shukla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India. Hauptthemen laut MEDLINE: Graphite, Nanocomposites, Transferrin, Drug Screening Assays, Antitumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur, Himachal Pradesh 176061, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
ORCID-Profile: Amitabha Acharya
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Shukla, A. K., Verma, M., Bathla, M., Randhawa, S., Saini, T. C., Kumari, A., & Acharya, A. (2024). Transferrin Immobilized Graphene Oxide Nanocomposite for Targeted Cancer Chemodynamic Therapy via Increasing Intracellular Labile Fe 2+ Concentration. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.3c01147
Vancouver
Shukla AK, Verma M, Bathla M, Randhawa S, Saini TC, Kumari A, et al. Transferrin Immobilized Graphene Oxide Nanocomposite for Targeted Cancer Chemodynamic Therapy via Increasing Intracellular Labile Fe 2+ Concentration. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.3c01147
BibTeX
@article{Shukla2024,
author = {Shukla, Ashish K and Verma, Mohini and Bathla, Manik and Randhawa, Shiwani and Saini, Trilok Chand and Kumari, Avnesh and Acharya, Amitabha},
title = {Transferrin Immobilized Graphene Oxide Nanocomposite for Targeted Cancer Chemodynamic Therapy via Increasing Intracellular Labile Fe 2+ Concentration},
journal = {ACS Applied Bio Materials},
year = {2024},
doi = {10.1021/acsabm.3c01147}
}
EUVIMED